business > medical coating
|
| RepelaCOAT™ |
| Anti-microbial Coating |
 |
| RepelaCOAT™coatings are |
|
| Effective: |
|
| RepelaCOAT™ prevents growth of commonly occurring organisms such as E. Coli, staph, and candida. |
|
| Safe: |
|
| RepelaCOAT™ maintains a slow release profile that minimizes toxicity to surrounding tissue. |
|
| Long Lasting: |
|
| RepelaCOAT™ has demonstrated effectiveness for up to 30 days. |
|
| Aqueous: |
|
| RepelaCOAT™ coatings, since they are based on the BioLAST platform, contain no organic solvents. Safer and cleaner manufacturing processes are used and any concerns about residual solvents in a device are eliminated. |
|
| Durable: |
|
| RepelaCOAT retains it's physical integrity even after hundreds of cycles. |
|
| Lubricious: |
|
| RepelaCOAT™ incorporates lubricious polymers that reduce patient trauma and increase ease of handling. |
|
|
|
|
|
|
| How does RepelaCOAT™ work? |
|
 |
|
|
| RepelaCOAT™ is part of the BioLAST technology platform. BioLAST's supporting polymer network is crosslinked and covalently bound to the substrate. This network is normally non-swellable in water. In this patent pending coating, silver salts and/or antibiotics are ionically bonded to the supporting polymer. In the presence of the sodium or calcium ions characteristic of body fluids, the anti-microbial agents ion exchange with these physiological cations. Long chain hydrophilic polymers incorporated in the coating adsorb water molecules and facilitate the ion exchange. Rather than exhibiting a huge "spike" of activity that diminishes rapidly over time and that may be toxic to the surrounding tissues RepelaCOAT™ prevents bacterial adherence by it's slow ion-exchange release of anti-microbial agents. |
|
|
|
| Anti-microbial Coating |
|
 Developed on BioLAST platform, RepelaCOAT™ is an infection-resistant medical device coating with a patent pending, ion-exchange release mechanism. Unlike most antimicrobial coatings that have only a brief, initial spike of activity, RepelaCOAT™ can be customized to have a controlled, initial "peak release" followed by a sustained release of anti-microbial agents in the presence of blood or urine. |
|
| Antimicrobial Profile - Silver Salt |
 |
|
| Antimicrobial Profile - Antibiotic |
 |
|
